You are here

Robert Bradway

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance

Clinical Trials Arena

Tue, 01/14/25 - 09:54 am

Amid pricing scrutiny, Amgen CEO predicts more value-based contracts

BioPharma Dive

Tue, 11/1/16 - 09:52 am

Amgen CEO wins kudos for bagging Onyx at reasonable price

Fierce Pharma

Wed, 08/28/13 - 10:47 am

ONYX Pharmaceuticals

Bradway salary jumps in first year as Amgen's CEO

News and Observer, NC

Tue, 04/9/13 - 10:25 am

Next Amgen CEO sees expansion to new markets, higher sales from newer products, share buybacks

Yahoo/AP

Tue, 01/10/12 - 09:05 am